allAfrica.com on MSN5d
Africa: A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major Conference
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
Healio6d
‘Early events’ can increase a person’s risk for long COVID
A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...
Medscape6d
Twice Daily TB Therapies Show Similar Neuropsychiatric Outcomes in Patients with HIV
Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...
HealthDay on MSN5d
Ensitrelvir Effectively Prevents Spread of COVID-19 in Households
For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at ...
Pulmonology Advisor14h
Ensitrelvir Effective for COVID-19 Prevention in Exposed Household Contacts
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
News244d
A jab that could protect against HIV for a year at a time
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
The Citizen4d
Cure trial shows promising results to suppress HIV without lifelong medication
The study aimed to reduce traces of HIV in the body and help the immune system fight the virus without chronic medication.
The Citizen on MSN1d
First HIV cure clinical trial in Africa shows promise in women
Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...
The Citizen6d
Groundbreaking HIV trial shows patients can control virus without ART
A pioneering study at UKZN has demonstrated that 20% of HIV patients in the trial remained off antiretroviral therapy while ...
AllAfrica on MSN1d
South Africa: Excitement Builds for Long-Acting TB Treatments, but Research Still At Early Stage
Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...
The Star on MSN6d
HIV cure trial led by Kenyan achieves viral suppression
The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...